Overview
Nisha Bansal is an Oncologist practicing medicine in Bronx, New York.
Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, and Bladder Reconstruction.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 Pelham Pkwy S, Bronx, NY 10461
Montefiore Medical Park At Eastchester
Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Halmos is currently accepting new patients.
Children's Hospital Of Montefiore
Deepa Manwani is a Hematologist and an Oncologist practicing medicine in Bronx, New York. Dr. Manwani is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
Montefiore Medical Center
Caterina Minniti is a Hematologist and an Oncologist practicing medicine in Bronx, New York. Dr. Minniti is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.
Montefiore Medical Park At 1575 Blondell
Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy. Dr. Gartrell is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.
Montefiore Centennial
Patrick F. Timmins III, MD, FACOG, FACS, is an attending physician at Montefiore Einstein and Vice Chair, Legislative Affairs at our Albert Einstein College of Medicine. Dr. Timmins addresses the individual needs and demands of patients in a warm and caring environment, providing a full range of gynecologic oncology services, including advanced gynecologic surgery, robotic surgery, chemotherapy treatment and palliative care. Dr. Timmins is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Bladder Reconstruction, and Hernia Surgery. Dr. Timmins is currently accepting new patients.
Frequently Asked Questions about Dr. Nisha Bansal
How do I make an appointment with Dr. Nisha Bansal?
You can book an appointment with Dr. Nisha Bansal by calling their office at 718-918-5700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nisha Bansal a top-rated expert for Malignant Mixed Mullerian Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nisha Bansal is classified as an Experienced expert for Malignant Mixed Mullerian Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nisha Bansal specialize in?
While Dr. Nisha Bansal is a Oncology, they have specific expertise in Malignant Mixed Mullerian Tumor, Endometrial Cancer, and Sertoli-Leydig Cell Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Nisha Bansal accept my insurance?
Dr. Nisha Bansal accepts most major insurance plans, including Anthem BCBS and Health First. We recommend calling the office directly at 718-918-5700 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder ReconstructionDr. Bansal isExperienced. Learn about Bladder Reconstruction.
- Cervical CancerDr. Bansal isExperienced. Learn about Cervical Cancer.
- Endometrial CancerDr. Bansal isExperienced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian TumorDr. Bansal isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CancerDr. Bansal isExperienced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Bansal isExperienced. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Bansal isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Bansal isExperienced. Learn about Testicular Yolk Sac Tumor.
- Vaginal CancerDr. Bansal isExperienced. Learn about Vaginal Cancer.
- Virilizing Ovarian TumorDr. Bansal isExperienced. Learn about Virilizing Ovarian Tumor.
- Vulvar CancerDr. Bansal isExperienced. Learn about Vulvar Cancer.



